Anthracycline based chemotherapies could have greater negative effects on cognition than nonanthracycline treatments for breast cancer survivors, a new study reports.
Researchers have shown that infrared and Raman spectroscopy – coupled with statistical analysis – can be used to tell the difference between normal brain tissue and the different tumor types that may arise in this tissue, based on its individual biochemical-cell ‘fingerprint’.
Researchers have developed a new method for creating custom tailored, two stage therapies for glioblastoma brain cancer.
Study shows how cholesterol becomes dysregulated in brain cancer cells and reports the gene responsible for the dysregulation could be a potential target to help treat glioblastoma brain cancer.
New findings could provide additional insight into the cause of glioblastoma and provide new options for personalized therapeutic treatments.
A new study reports researchers have discovered a way to enhance the effects of immunotherapy to treat glioblastoma.
Researchers report our gender can determine longevity and response to treatment for glioblastoma brain cancer. The study reports male survival is determined by genes that control cell division, where as female survival is often determine by genes that regulate the ability of cancer cells to migrate to different brain areas.